tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ABCL is currently covered by 6 analysts with an average price target of $12.65. This is a potential upside of $10.24 (424.9%) from yesterday's end of day stock price of $2.41.
Abcellera Biologics 's activity chart (see below) currently has 36 price targets and 43 ratings on display. The stock rating distribution of ABCL is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 9.18% with an average time for these price targets to be met of 19.43 days.
Highest price target for ABCL is $5, Lowest price target is $5, average price target is $15.5.
Most recent stock forecast was given by SCOTT SCHOENHAUS from KEYBANK on 16-Apr-2025. First documented stock forecast 05-Jan-2021.
Currently out of the existing stock ratings of ABCL, 16 are a BUY (80%), 4 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$2.59 (107.47%)
$4
18 days ago
(16-Apr-2025)
0/6 (0%)
$2.61 (109.21%)
Hold
2 months 1 days ago
(03-Mar-2025)
0/2 (0%)
$6.55 (120.18%)
Buy
$5
$2.59 (107.47%)
$22
5 months 29 days ago
(05-Nov-2024)
0/4 (0%)
$2.28 (83.82%)
Buy
$24
$21.59 (895.85%)
$30
1 years 9 months ago
(04-Aug-2023)
0/2 (0%)
$17.96 (297.35%)
Buy
$28
$25.59 (1061.83%)
$34
1 years 11 months 29 days ago
(05-May-2023)
1/6 (16.67%)
$22.01 (367.45%)
24
What is ABCL (Abcellera Biologics ) average time for price targets to be met?
Which analyst has the current highest performing score on ABCL (Abcellera Biologics ) with a proven track record?
Which analyst has the current lower performing score on ABCL (Abcellera Biologics ) with a proven track record?
Which analyst has the most public recommendations on ABCL (Abcellera Biologics )?
Which analyst is the currently most bullish on ABCL (Abcellera Biologics )?
Which analyst is the currently most reserved on ABCL (Abcellera Biologics )?
